Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.680
-0.220 (-4.49%)
Aug 1, 2025, 10:32 AM EDT
Everi Holdings Revenue
In the year 2022, Veradigm had annual revenue of $588.02M with 1.83% growth. Veradigm had revenue of $151.92M in the quarter ending September 30, 2022, with 5.01% growth.
Revenue
588.02M
Revenue Growth
+1.83%
P/S Ratio
1.42
Revenue / Employee
240.01K
Employees
2,450
Market Cap
832.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 588.02M | 10.59M | 1.83% |
Dec 31, 2021 | 577.43M | 21.31M | 3.83% |
Dec 31, 2020 | 556.12M | -1.08B | -65.94% |
Dec 31, 2019 | 1.63B | 14.77M | 0.91% |
Dec 31, 2018 | 1.62B | 120.13M | 8.02% |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
BioStem Technologies | 332.45M |
Veradigm News
- 5 weeks ago - Veradigm Provides 2025 Financial & Business Update - Business Wire
- 6 weeks ago - Veradigm to Release Business Update June 23rd and Host Investor Call June 24th - Business Wire
- 2 months ago - Veradigm Launches Smart Medicine Podcast to Explore the Evolution of Healthcare - Business Wire
- 2 months ago - Veradigm Recognized with KLAS 2025 Points of Light Award for Optimizing Value-Based Care - Business Wire
- 2 months ago - Veradigm Advances GLP-1 Real-World Evidence Generation with AI-Driven EHR Data Curation - Business Wire
- 4 months ago - Black Book Ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solution Vendor in 2025 - Business Wire
- 4 months ago - Syracuse Orthopedic Specialists Selects Veradigm to Achieve Exceptional Financial Health and Operational Efficiency - Business Wire
- 4 months ago - Veradigm Inc. (MDRX) Investor Update Call Transcript - Seeking Alpha